Web11 de out. de 2024 · It can be applied independently or together with other pharmaceutical products to inhibit tumor growth and prevent tumor recurrence. Type: Application. Filed: August 17, 2024. Publication date: September 19, 2024. Applicant: HIGHFIELD BIOPHARMACEUTICAL CORPORATION. Inventors: YUHONG XU, XIAOLONG CHEN, … Web17 de ago. de 2024 · The present disclosure provides an all-trans retinoic acid injectable formulation and its application for a preparation of a pharmaceutical product for treating tumor. The all-trans retinoic acid injectable formulation includes all-trans retinoic acid and solubilizers. The apparent solubility of the all-trans retinoic acid is increased from 0.01 …
HighField BioPharmaceutical Corporation - Entity RPX Insight
WebAbout us. SparX Biopharmaceutical Corp. is a research-based development-stage biopharmaceutical company, dedicated to the mission of “strengthening human … WebTraining Resources. From books to videos, we have developed training materials & resources to provide your learners with essential knowledge and help them achieve. With digital and hard copy options in a wide range of subjects, we have training resources that cater for different learner situations in all industries. notorious lightning and other works
HighField Biopharmaceuticals
Web8 de jul. de 2024 · Sparx Therapeutics is an integrated biopharmaceutical company based in Chicago. Since its incorporation in 2024, Sparx has built a sophisticated multi-specific antibody drug discovery platform and ... WebWe are a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology for the prevention and treatment of cancer based on our … Web11 de out. de 2024 · Patents Assigned to HIGHFIELD BIOPHARMACEUTICAL CORPORATION IRINOTECAN LIPOSOME PREPARATION, AND PREPARATION AND … notorious lipstick